期刊
PATHOLOGY RESEARCH AND PRACTICE
卷 210, 期 8, 页码 477-481出版社
ELSEVIER GMBH
DOI: 10.1016/j.prp.2014.03.013
关键词
Carcinoma; Hepatocellular; Activating transcription factor 3 (ATF3); Gene expression
类别
资金
- Specialized Research Foundation for the doctoral program of Chinese Higher Education [20093518110001]
- Fujian Medical University Key Research Project Foundation of China [09ZD007]
Background and Aim: To explore the expression and role of activating transcription factor 3 in human hepatocellular carcinoma. Methods: Immunohistochemistry, Western blot assay and Real-time PCR were used to evaluate activating transcription factor 3 protein and gene level in HCC clinical samples. Results: Activating transcription factor 3 expression is lowest in HCC, and the protein level is lower in patients with capsule invasion, while there is no association with other main clinical pathological features. Conclusions: Low expression of ATF3 may function as a tumor suppressor during human hepatocellular oncogenesis and targeting ATF3 pathway might be beneficial for anti-HCC therapy. (C) 2014 Published by Elsevier GmbH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据